Antimicrobial resistance among Gram-negative agents of bacteraemia in the UK and Ireland: trends from 2001 to 2019
Journal of Antimicrobial Chemotherapy · 2025
DOI: 10.1093/jac/dkaf250 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2025. Verfasst von Rosy Reynolds und 10 weiteren Autor:innen. Beteiligte Einrichtung: Population Health Sciences, University of Bristol, Bristol BS8 2PS, UK. Hauptthemen laut MEDLINE: Bacteremia, Anti-Bacterial Agents, Gram-Negative Bacteria, Gram-Negative Bacterial Infections. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the British Society for Antimicrobial Chemotherapy, Abbott, Astellas.
Abstract (Originalsprache)
Objectives
The BSAC Bacteraemia Resistance Surveillance Programme collected isolates from UK and Irish hospitals for central testing. Concurrent UKHSA surveillance collected English hospitals’ own susceptibility data. Results were reviewed and compared.
Methods
The BSAC surveillance collected fixed quotas of isolates per site annually from 2001 to 2019. MIC testing was by BSAC agar dilution. Resistance mechanisms were investigated by synergy tests, interpretive reading and PCR. The UKHSA seeks data on all bacteraemia isolates in England.
Results
For Escherichia coli, which now causes >30% of all bacteraemias, there were marked early (2002–06) rises in resistance to cephalosporins, fluoroquinolones and gentamicin, followed by small falls, stabilization, then from around 2015, very slow rises, with similar patterns seen for Klebsiella pneumoniae. Most cephalosporin resistance in these two species involved ESBLs, principally CTX-M types. Both species had frequent co-amoxiclav resistance. Cephalosporin resistance—mostly AmpC-mediated—declined in Enterobacter and Serratia spp., as did fluoroquinolone resistance, likely reflecting reduced use and selection pressure. Proteeae showed few changes; increasing dominance of Proteus mirabilis in the BSAC collection was not confirmed by the UKHSA dataset. Resistance in Pseudomonas aeruginosa was uncommon and showed little temporal change in either dataset. Carbapenemases remained extremely rare in all species. Newer and developmental agents covered many resistance types, but none covered all types.
Conclusions
Except for early rises of cephalosporin, fluoroquinolone and gentamicin resistance in E. coli and K. pneumoniae, there was little evidence for rising resistance and some evidence of declining resistance, notably in species where it predominantly involves AmpC derepression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Population Health Sciences, University of Bristol, Bristol BS8 2PS, UK.
- British Society for Antimicrobial Chemotherapy, 53 Regent Place, Birmingham B1 3NJ, UK.
- Antimicrobial Resistance and Healthcare Associated Infections Reference Unit, UK Health Security Agency, Colindale, London NW9 5EQ, UK.
- Antimicrobial Resistance and Healthcare Associated Infections Division, UK Health Security Agency, Colindale, London NW9 5EQ, UK.
- Medical Affairs, MSD (UK) Limited, 120 Moorgate, London EC2M 6UR, UK.
- Scientific Affairs, Shionogi B.V., Fifty Paddington, 50 Eastbourne Terrace, Paddington W2 6LG, UK.
ORCID-Profile: Shazad Mushtaq, Russell Hope, Christopher Longshaw
Förderung
- the British Society for Antimicrobial Chemotherapy
- Abbott
- Astellas
- AstraZeneca
- Aventis
- Basilea
- Bayer
- Cempra
Zitieren
APA
Reynolds, R., Mushtaq, S., Hope, R., Horner, C., Adkin, R., Chaudhry, A., Nsonwu, O., Allen, M., Longshaw, C., Parcell, B. J., & Livermore, D. M. (2025). Antimicrobial resistance among Gram-negative agents of bacteraemia in the UK and Ireland: trends from 2001 to 2019. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkaf250
Vancouver
Reynolds R, Mushtaq S, Hope R, Horner C, Adkin R, Chaudhry A, et al. Antimicrobial resistance among Gram-negative agents of bacteraemia in the UK and Ireland: trends from 2001 to 2019. Journal of Antimicrobial Chemotherapy. 2025. doi:10.1093/jac/dkaf250
BibTeX
@article{Reynolds2025,
author = {Reynolds, Rosy and Mushtaq, Shazad and Hope, Russell and Horner, Carolyne and Adkin, Rachael and Chaudhry, Aiysha and Nsonwu, Olisaeloka and Allen, Michael and Longshaw, Christopher and Parcell, Benjamin J and Livermore, David M},
title = {Antimicrobial resistance among Gram-negative agents of bacteraemia in the UK and Ireland: trends from 2001 to 2019},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2025},
doi = {10.1093/jac/dkaf250}
}
EUVIMED